Results 371 to 380 of about 194,026 (392)

Lung cancer: New biological insights and recent therapeutic advances

Ca-A Cancer Journal for Clinicians, 2011
Suresh S Ramalingam, Fadlo R Khuri
exaly  

NTRK fusion-positive cancers and TRK inhibitor therapy

Nature Reviews Clinical Oncology, 2018
Emiliano Cocco, Maurizio Scaltriti, Alexander Drilon   +2 more
exaly  

Proton-pump-inhibitors

Reactions Weekly
  +5 more sources

The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy

Nature Reviews Cancer, 2019
Jonathan J Havel, Diego Chowell, Timothy A Chan   +2 more
exaly  

Appraising iniparib, the PARP inhibitor that never was—what must we learn?

Nature Reviews Clinical Oncology, 2013
Joaquin Mateo, Michael Ong, David S P Tan   +2 more
exaly  

Proton pump inhibitors

Reactions Weekly, 2007
openaire   +1 more source

Oral microbiome alterations of healthy volunteers with proton pump inhibitor

Journal of Gastroenterology and Hepatology, 2018
Tsuyoshi Mishiro, K. Oka, Y. Kuroki, Motomichi Takahashi, Kasumi Tatsumi, Tsukasa Saitoh, Hiroshi Tobita, N. Ishimura, Shuichi Sato, S. Ishihara, J. Sekine, K. Wada, Y. Kinoshita   +12 more
semanticscholar   +1 more source

Proton pump inhibitors

Reactions Weekly, 2022
openaire   +1 more source

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Cell, 2020
Markus Hoffmann, Nadine Krüger, Tobias S Schiergens   +2 more
exaly  

An inhibitor of oxidative phosphorylation exploits cancer vulnerability

Nature Medicine, 2018
Yuting Sun, Jeffrey J Ackroyd, Stefan O Ciurea   +2 more
exaly